MARLBOROUGH, Mass. -- SCIEX, a Danaher company and leader in life science analytical technologies, highlighted six industry collaborations as it continues to build an integrated software environment with SCIEX software solutions. The result is a scalable, analytically rigorous software environment engineered to meet the evolving and complex needs of modern labs. By unifying instrument control, [...]

Bracco's new BubbleGen technology streamlines cell therapy manufacturing for one-step cell separation and activation with no magnetic residuals  BubbleGen microbubbles can target specific cell subtypes, including rare populations  Demos available for BubbleGen at ISCT, Booth #2711 Princeton, NJ - Bracco Imaging, a global pharmaceutical company that develops, manufactures, and markets innovative healthcare solutions, unveiled its Early [...]

New analysis suite helps cell engineering teams benchmark target identity, detect off-target states, and prioritize protocol improvements ST. LOUIS -- CapyBio, a cell identity tools and services company, today announced the launch of three new commercial analysis services: Capybara™ Benchmarking Analysis, Capybara Advanced Analysis, and CellOracle™ Differentiation Optimization Analysis. Together, these services help cell engineering teams [...]

IRVINE, Calif. - GeneTex, a multinational recombinant antibody manufacturer, is excited to announce the formalization of a collaborative relationship with the renowned Human Protein Atlas (HPA), a peerless, open-access multi-laboratory organization whose primary goal is to establish a comprehensive map of the human proteome using an integrated omics approach involving antibody-based proteomics and transcriptomics. The HPA's importance [...]

Partnership integrates RoosterBio's mesenchymal stem cell and extracellular vesicle platforms into Made Scientific's end-to-end CDMO capabilities to accelerate development and commercial-scale production of advanced therapies PRINCETON, N.J. and FREDERICK, Md. -- Made Scientific, Inc., a U.S.-based clinical and commercial cell therapy contract development and manufacturing organization (CDMO), and RoosterBio, Inc., a leading supplier of human mesenchymal [...]

New Gibco™ CTS™ DynaXS™ Single Use Bioreactor supports flexible, cGMP-ready cell expansion from process development to clinical production to support the development of cell therapies for cancer, autoimmune, and other treatments WALTHAM, Mass. -- Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Gibco™ CTS™ DynaXS™ Single Use Bioreactor, a purpose-built [...]

LOVELAND, Colo. -- Today, Hach unveils the DR4900 Spectrophotometer to meet laboratories' demand for accurate, efficient, and user-friendly water analysis. Built on Hach's legacy of trusted spectrophotometry technology since 1955, the DR4900 is a next-generation instrument engineered to empower lab professionals in municipal and industrial facilities to achieve precise results. The DR4900 maintains the trusted [...]

Synthesis of structurally complex and highly-engineered protein sequences to enable acceptance of approximately 99.5% of clonal gene orders and 99.9% of all DNA products Complex synthesis capabilities to support further advancement of AI-enabled drug discovery and nucleic acid therapeutics SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, [...]

Seasoned life sciences executive brings extensive global commercial leadership to accelerate growth and expand adoption of Seer’s Proteograph® Product Suite REDWOOD CITY, Calif. -- Seer, Inc. (Nasdaq: SEER), a pioneer and trusted partner for deep, unbiased proteomic insights, today announced the appointment of Anthony Bazarko as Chief Commercial Officer. Mr. Bazarko brings more than two decades [...]

SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced the appointment of Michael Buckner as chief legal officer, effective today. Buckner brings nearly three decades of experience as a senior global legal executive, with a proven track record of building and leading high-performing teams and deep expertise in complex transactions and regulatory environments. [...]